Intelligo

Public limited company · Oslo

THOR MEDICAL ASA

ActiveResearch and experimental development on natural sciences and engineering (72.100)

Founded
2 Jul 2009
Employees
25
Chief executive
Jasper Cornelius Kurth
Business address
Drammensveien 167, 0277 Oslo

The life line 2009–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 839k.

  1. Kapital§ 14
  2. Chair took office§ 07
  3. Managing director took office§ 07
  4. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

THOR MEDICAL ASA is a public limited company in Oslo, founded in 2009, in the industry research and experimental development on natural sciences and engineering. The chief executive is Jasper Cornelius Kurth, and the chair of the board is John Andersen. In 2025 the company had NOK 839k in operating revenue and a net profit of NOK −42.5m; the group had revenue of NOK 839k. The largest owner is SCATEC INNOVATION AS with 23.2%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 13 Nov 2026

  • Number of employees 23 → 25
  • Number of employees 22 → 23
  • Changed capital 360001820 → 422501820
  • Changed capital 72000364 → 84500364

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

2 points

  • NoteOperating loss three years running, 2023–2025
  • OKEquity ratio 93.8%, above the industry median

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 839k in 2025

Revenue

NOK 839k

— from 2024

20232025

Operating profit

NOK −50.4m

−20.2% from 2024

20232025

Net profit

NOK −42.5m

−4.6% from 2024

20232025

Equity

NOK 475.9m

+39.4% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 3,932%
  • Depreciation 14%
  • Other operating costs 2,164%

Costs exceeded revenue: the operating result was NOK −50.4m.

Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 93.8%

RevenueNOK 839k Operating margin−6,009.9% Equity ratio93.8%
  • THOR MEDICAL ASA, 2025
  • Industry median, assumed: NOK 1.5m · −4.4% · 48.9%

Equity NOK 475.9m94% of the assets (NOK 507.4m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 694 companies in 72.100 Research and experimental development on natural sciences and engineering, not stated by the source.

Finances

§ 06 Accounts

17 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue839—0
Operating profit−50,423−41,946−4,356
Profit before tax−42,468−40,593−2,855
Net profit−42,468−40,593−2,855
Total assets507,350363,926278,406
Equity475,867341,463274,629
Liabilities31,48222,4623,777

Source: the Register of Company Accounts, read 15 Nov 2026 · All 17 years →

Management and ownership

§ 07 Officers

8 officers now

The board: 5 members

Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 8 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Styrets leder og ett styremedlem i fellesskap.

May sign for the company:

Styrets leder og ett styremedlem i fellesskap.

Power of procuration:

Daglig leder alene.

The board has 1 authorisation in force now: capital increase, until 30 Jun 2027.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 25 Aug 2026

Management and ownership

§ 09 Owners

762 shareholders · largest 23.2%

OwnerShare
SCATEC INNOVATION AS
23.2%
OLILI AS
5.1%
ROHT INVEST AS
4.1%
759 others67.6%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 762 owners →

Management and ownership

§ 10 Group

1 subsidiary

THOR MEDICAL ASA parent company

The group 2025: operating revenue NOK 839k.

Share held. Source: the Tax Administration's shareholder register, fetched 30 Jul 2026 · The whole group →

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

35 connections

  • Person
  • Company

4 people link THOR MEDICAL ASA to 31 other companies: John Andersen 16, Mimi Kristine Berdal 10, Thomas Ramdahl 5 and Jens Gisle Schnelle 1.

Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →

Events and registers

§ 13 Events

159 since 2015

Events per year

20152026

  • Notices220
  • Register changes8
  • Owners in and out5

Since 2015: 220 announcements, 8 register changes and 4 new and 1 former owners. Most happened in 2019 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 159 events →

Events and registers

§ 14 Notices

220, latest 10 Sep 2026

  • Kapital
  • Vedtektsdato
  • Godkjente årsregnskap

Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 220 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 7 Jul 2009
  • VATRegistered
  • The Register of Business EnterprisesRegistered 7 Jul 2009
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Levere alfaemittere til leverandører og utviklere av innovative legemidler som retter seg mot indikasjoner med høyt udekket medisinsk behov, inkludert eventuelle medisinske produkter og utstyr, og å drive virksomhet relatert til dette eller forbundet med dette.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 72.100

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

7 questions

  • Who is the chief executive of THOR MEDICAL ASA?
    Jasper Cornelius Kurth, since 2024. § 07
  • Who owns THOR MEDICAL ASA?
    762 shareholders. The largest is SCATEC INNOVATION AS with 23.2%, OLILI AS with 5.1% and ROHT INVEST AS with 4.1%. § 09
  • What was the revenue in 2025?
    NOK 839k in the company and NOK 839k in the group. § 06
  • Who can sign for THOR MEDICAL ASA?
    Styrets leder og ett styremedlem i fellesskap. § 08
  • Who is the auditor?
    ERNST & YOUNG AS, from 27 May 2014. § 07
  • Where is THOR MEDICAL ASA based?
    Drammensveien 167, 0277 Oslo.
  • When was THOR MEDICAL ASA founded?
    2 Jul 2009, registered in the Register of Business Enterprises 7 Jul 2009. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose